DNAH3

Chr 16

dynein axonemal heavy chain 3

Also known as: DNAHC3-B, DNAHC3B, HDHC8, HEL-36, HSADHC3

This gene belongs to the dynein family, whose members encode large proteins that are constituents of the microtubule-associated motor protein complex. This complex is composed of dynein heavy, intermediate and light chains, which can be axonemal or cytoplasmic. This protein is an axonemal dynein heavy chain. It is involved in producing force for ciliary beating by using energy from ATP hydrolysis. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Dec 2016]

OMIMResearchGenerating clinical summary…
MultiplemechanismLOEUF 0.80
Clinical SummaryDNAH3
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
4 unique Pathogenic / Likely Pathogenic· 666 VUS of 789 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.80LOEUF
pLI 0.000
Z-score 3.96
OE 0.69 (0.600.80)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.03Z-score
OE missense 1.00 (0.961.03)
2256 obs / 2260.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.69 (0.600.80)
00.351.4
Missense OE?1.00 (0.961.03)
00.61.4
Synonymous OE?1.09
01.21.6
LoF obs/exp: 132 / 191.1Missense obs/exp: 2256 / 2260.0Syn Z: -2.13

This gene — mechanism propensity

DN
0.6356th %ile
GOF
0.74top 25%
LOF
0.2386th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

789 submitted variants in ClinVar

Classification Summary

Pathogenic1
Likely Pathogenic3
VUS666
Likely Benign61
Benign18
Conflicting5
1
Pathogenic
3
Likely Pathogenic
666
VUS
61
Likely Benign
18
Benign
5
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
1
0
0
1
Likely Pathogenic
1
2
0
0
3
VUS
4
660
1
1
666
Likely Benign
0
39
2
20
61
Benign
0
4
3
11
18
Conflicting
5
Total5706632754

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

14 pathogenic / likely-pathogenic (of 21) ClinVar copy-number / structural variants overlap DNAH3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

DNAH3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →